Saturday, June 19, 2021 5:43:24 PM
The SLB metric was an accurate predictor of the last Short & Distort attack (https://www.investopedia.com/terms/s/shortanddistort.asp) against AVXL, in November 2015 I think. The SLB was high and trending higher in the few weeks before a major release of data results and spiked to way over 100% a day or two prior to the release. That was the Short part, and the key indicator that a distortion campaign would follow. What hedge fund manager would risk multiple millions in a huge short against results yet to be revealed without having a way to ensure their bet would win?
The Distort part of the crime started weeks before the data release with several baseless attack articles, but shifted into high gear right on the heels of the extremely positive news press release of data results from Anavex. Hit pieces were published all day and for the next several days, beginning with a long one that was published within 3 minutes of the press release revealing the data. It is impossible that such a long article could have been written in such a short time after the press release. It had to have been written beforehand. It was a generic attack full of baseless and irrelevant criticisms of the company and disparaging the astonishingly good news without citing any valid criticisms. Many more articles followed, having taken the time to at least skim the data results to cite something specific and to then level an invalid criticism. Often these articles cited old defamatory claims that had been debunked repeatedly on the old Yahoo message board.
High-frequency trading rode the coattails of the distortions and succeeded in driving the price/share down sharply, which caught countless stop-loss orders on the way down, each of which accelerated the price drop.
A Short & Distort attack is fraud, and it is a crime. Complaints were filed at the SEC, and the SEC did nothing, as the SEC has never done anything to fight these types of crime.
This time the SLB rate is near rock bottom. There is no rise in the rate, so there is no sustained rise. That is the strongest possible signal I am aware of that no S&D attack preparation has begun. If I see that change, I will post that information on this board immediately.
I think a late-starting S&D attack is not likely to come for 2 main reasons:
1.) WallStreetBets hammered the major shorts for multiple billions in losses, and they do not appear to have returned to business as was usual.
2.) The recent peer-reviewed article may have destroyed the ability for corrupt financial "journalists" and others to successfully but falsely claim that Anavex 2-73 is based on bad science or raise irrelevant issues.
I suspect we are about to see what would have happened in November 2015 if there had not been a fraudulent S&D attack against Anavex.
-------------------------------------
If you want a little more insight into those old days, here is a rebuttal article I wrote to a hit piece published shortly before the data release, I think: https://seekingalpha.com/instablog/40909465-jdlambert/4535316-anavex-life-sciences-attacked-hack-too-many-dishonest-red-flags
Recent AVXL News
- Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024 • GlobeNewswire Inc. • 10/31/2024 08:00:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • InvestorsHub NewsWire • 10/23/2024 12:03:31 PM
- Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia • GlobeNewswire Inc. • 10/17/2024 11:30:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • InvestorsHub NewsWire • 10/15/2024 12:21:48 PM
- ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • InvestorsHub NewsWire • 10/01/2024 11:00:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM